SQI Diagnostics Announces New Capital Markets Consulting Agreement
TORONTO, March 13, 2023 /PRNewswire/ – SQI Diagnostics Inc. (“SQI” or the “Company”) (TSXV: SQD) (OTCQB: SQIDF), a leader in the science of lung health that develops and manufactures respiratory health and precision medicine tests today announces that it has entered into a new consulting…
Comments Off on SQI Diagnostics Announces New Capital Markets Consulting Agreement